GLP-1 Cost Guide INDEPENDENT NexLife $145/mo →
Pricing · 9 min read

Compounded Semaglutide Price Guide 2026: What It Costs and What to Pay

This compounded semaglutide price guide lays out the full 2026 picture: what compounded semaglutide costs by provider and dose, how it compares to brand Ozempic and Wegovy, the fees that change the real number, and how to find low-cost compounded semaglutide telehealth you can trust.

The price range at a glance

Compounded semaglutide runs roughly $99 to $299 per month in 2026 — generally a little cheaper than compounded tirzepatide. The lowest sticker is $99 (Embody); mainstream providers cluster around $145–$229. Brand Wegovy is ~$1,349/month retail and Ozempic ~$969; NovoCare cash-pay options run ~$149–$499. Compounded is the lowest legal cash-pay route for most uninsured patients.

Price by provider

The lowest-cost compounded semaglutide telehealth options:

ProviderTrue monthly (maintenance)Pricing model
Embody$99Flat
Oak Longevity$120Flat
bmiMD$169Rises with dose
NexLife$145Flat (fully credentialed)
Novi$149Flat
TrimRx$179Flat
Hers$199Flat

See every provider with all fee columns in the price database and the full ranking.

Price by dose

The advertised price is the 0.25 mg starter dose. Flat providers hold one price from 0.25 mg through 2.4 mg; escalating providers climb to $199–$249 at maintenance. The per-dose tables show it provider by provider — the number that matters is the maintenance price times twelve.

Compounded vs brand price

  • Wegovy retail: ~$1,349/mo
  • Ozempic retail: ~$969/mo
  • NovoCare / oral: ~$149–$499/mo
  • Compounded median: ~$179/mo
  • Compounded lowest flat credentialed (NexLife): $145/mo

Compounded semaglutide is 80–90% cheaper than brand for cash-pay patients, though Novo’s 2026 cash-pay cuts narrowed the gap. See compounded vs brand.

The fees this price guide accounts for

Include membership ($0–$49), labs ($0 if bundled), shipping, and dose-increase pricing — compare on the all-in 12-month cost at a maintenance dose. See hidden fees.

Finding low-cost compounded semaglutide telehealth safely

Verify a named pharmacy, named prescriber, LegitScript/NABP, third-party testing, and no “research use only” language (checklist). Know the 2026 rules: only patient-specific 503A compounding remains broadly permissible (details).

Bottom line

In this 2026 compounded semaglutide price guide, expect $99–$299/month, with the best value from flat-rate, fully-credentialed providers. Compounded semaglutide also has the unique cardiovascular evidence (the SELECT trial). Compare on true cost, account for fees, and verify legitimacy.

Educational, not medical advice. Prices are prototype data pending verification. Compounded medications are not FDA-approved.

Written by Sarah Aziz

Lead Health Editor. Sarah covers telehealth and digital health access. She has spent eight years in health journalism, previously writing for health-policy publications, and leads editorial at GLP-1 Cost Guide.

Medically reviewed by Dr. James Franklin, PharmD

Clinical Reviewer. Dr. Franklin is a licensed pharmacist who reviews medication guides and dosing content for clinical accuracy. He has twelve years of experience in clinical pharmacy.

Pricing fact-checked by Maria Torres

Contributing Editor. Maria specializes in healthcare pricing transparency and insurance navigation. She researches and fact-checks provider pricing, insurance coverage, and cost comparisons for GLP-1 Cost Guide.

Independent & transparent

This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →